论文部分内容阅读
目的:了解医院常用心血管类中成药的应用情况,分析治疗心血管疾病类中成药的用药趋势,为临床合理用药提供参考。方法:选择本院2012-2014年心血管类中成药的品种、剂型、销售金额、用药频度(DDDs)等进行统计分析。结果:本院心血管类中成药的销售金额呈逐年小幅度增长趋势,药物销售金额及DDDs最高的5位分别是复方丹参滴丸、血塞通注射液、丹参注射液、参松养心胶囊、银杏叶胶囊,3年间DDDs前10位的药品无大变化,其排序波动不大,中成药的DDDs、用药金额(DDC)排序表明,多数中成药使用率较高、价格相对低廉。结论:本院心血管类中成药的使用基本合理,其销售数量及销售金额呈小幅度增长趋势,在心血管类疾病的治疗及预防方面逐渐显现出重要作用。
Objective: To understand the application of cardiovascular commonly used proprietary Chinese medicines in hospitals, to analyze the trend of drug use in the treatment of cardiovascular diseases and to provide a reference for clinical rational drug use. Methods: The types, dosage forms, sales amount, medication frequency (DDDs) of the cardiovascular Chinese patent medicines in our hospital from 2012 to 2014 were selected for statistical analysis. Results: The sales amount of cardiovascular proprietary Chinese medicine in our hospital showed a slight increase year by year. The top five sales amount and DDDs were compound Danshen dripping pills, Xuesaitong injection, Danshen injection and Shensongyangxin capsule , Ginkgo biloba capsules, DDDs three years before the big change in the top 10 drugs, the order was not volatile, DDDs of traditional Chinese medicine, drug amount (DDC) ranking shows that the majority of proprietary Chinese medicines higher rates, the price is relatively low. Conclusion: The use of proprietary Chinese medicines for cardiovascular system in our hospital is basically reasonable. The sales amount and sales amount show a small increase trend, and gradually show an important role in the treatment and prevention of cardiovascular diseases.